Prevalence and molecular characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis isolates from Southern China
Abstract Background Pyrazinamide (PZA) plays a unique role in the treatment for multidrug-resistant tuberculosis (MDR-TB) in both first- and second-line regimens. The aim of this study was to investigate the prevalence and molecular characterization of PZA resistance among MDR-TB isolates collected...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-11-01
|
Series: | BMC Infectious Diseases |
Online Access: | http://link.springer.com/article/10.1186/s12879-017-2761-6 |
id |
doaj-1d34afff2ae741ffbf7a72a979537a04 |
---|---|
record_format |
Article |
spelling |
doaj-1d34afff2ae741ffbf7a72a979537a042020-11-25T02:36:40ZengBMCBMC Infectious Diseases1471-23342017-11-011711810.1186/s12879-017-2761-6Prevalence and molecular characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis isolates from Southern ChinaYu Pang0Damian Zhu1Huiwen Zheng2Jing Shen3Yan Hu4Jie Liu5Yanlin Zhao6National Clinical Laboratory on Tuberculosis, Beijing Key Laboratory on Drug-Resistant Tuberculosis Research, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor InstituteClinical Laboratory, Chongqing Tuberculosis Control InstituteNational Center for Tuberculosis Control and Prevention, Chinese Center for Disease Control and PreventionClinical Laboratory, Chongqing Tuberculosis Control InstituteClinical Laboratory, Chongqing Tuberculosis Control InstituteClinical Laboratory, Chongqing Tuberculosis Control InstituteNational Center for Tuberculosis Control and Prevention, Chinese Center for Disease Control and PreventionAbstract Background Pyrazinamide (PZA) plays a unique role in the treatment for multidrug-resistant tuberculosis (MDR-TB) in both first- and second-line regimens. The aim of this study was to investigate the prevalence and molecular characterization of PZA resistance among MDR-TB isolates collected in Chongqing municipality. Methods A total of 133 MDR-TB isolates were collected from the smear-positive tuberculosis patients who were registered at local TB dispensaries of Chongqing. PZA susceptibility testing was determined with a Bactec MGIT 960 system. In addition, the genes conferring for PZA resistance were screened by DNA sequencing. Results Of these 133 MDR-TB isolates, 83 (62.4%) were determined as PZA-resistant by MGIT 960. In addition, streptomycin- (83.1% vs. 56.0%, P < 0.01), ofloxacin- (51.8% vs. 18.0%, P < 0.01), kanamycin- (22.9% vs. 2.0%, P < 0.01), amikacin- (18.1% vs. 2.0%, P = 0.01), capromycin-resistance (12.0% vs. 2.0%, P = 0.05), were more frequently observed among PZA-resistant isolates compared with PZA-susceptible isolates. Sequence analysis revealed that 73 out of 83 (88.0%) MDR strains harbored a mutation located in the pncA gene, including 55 (75.3%, 55/73) of single nucleotide substitutions and 18 (24.7%, 18/73) of frameshift mutation, while no genetic mutation associated with PZA resistance was found in the rpsA gene. The pncA expression of strains harboring substitution from A to G at position −11 in the promoter region of pncA was significantly lower than that of H37Rv (P < 0.01). Conclusions In conclusion, our data have demonstrated that the analysis of the pncA gene rather than rpsA gene provides rapid and accurate information regarding PZA susceptibility for MDR-TB isolates in Chongqing. In addition, loss of pncA expression caused by promoter mutation confers PZA resistance in MDR-TB isolates.http://link.springer.com/article/10.1186/s12879-017-2761-6 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Yu Pang Damian Zhu Huiwen Zheng Jing Shen Yan Hu Jie Liu Yanlin Zhao |
spellingShingle |
Yu Pang Damian Zhu Huiwen Zheng Jing Shen Yan Hu Jie Liu Yanlin Zhao Prevalence and molecular characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis isolates from Southern China BMC Infectious Diseases |
author_facet |
Yu Pang Damian Zhu Huiwen Zheng Jing Shen Yan Hu Jie Liu Yanlin Zhao |
author_sort |
Yu Pang |
title |
Prevalence and molecular characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis isolates from Southern China |
title_short |
Prevalence and molecular characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis isolates from Southern China |
title_full |
Prevalence and molecular characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis isolates from Southern China |
title_fullStr |
Prevalence and molecular characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis isolates from Southern China |
title_full_unstemmed |
Prevalence and molecular characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis isolates from Southern China |
title_sort |
prevalence and molecular characterization of pyrazinamide resistance among multidrug-resistant mycobacterium tuberculosis isolates from southern china |
publisher |
BMC |
series |
BMC Infectious Diseases |
issn |
1471-2334 |
publishDate |
2017-11-01 |
description |
Abstract Background Pyrazinamide (PZA) plays a unique role in the treatment for multidrug-resistant tuberculosis (MDR-TB) in both first- and second-line regimens. The aim of this study was to investigate the prevalence and molecular characterization of PZA resistance among MDR-TB isolates collected in Chongqing municipality. Methods A total of 133 MDR-TB isolates were collected from the smear-positive tuberculosis patients who were registered at local TB dispensaries of Chongqing. PZA susceptibility testing was determined with a Bactec MGIT 960 system. In addition, the genes conferring for PZA resistance were screened by DNA sequencing. Results Of these 133 MDR-TB isolates, 83 (62.4%) were determined as PZA-resistant by MGIT 960. In addition, streptomycin- (83.1% vs. 56.0%, P < 0.01), ofloxacin- (51.8% vs. 18.0%, P < 0.01), kanamycin- (22.9% vs. 2.0%, P < 0.01), amikacin- (18.1% vs. 2.0%, P = 0.01), capromycin-resistance (12.0% vs. 2.0%, P = 0.05), were more frequently observed among PZA-resistant isolates compared with PZA-susceptible isolates. Sequence analysis revealed that 73 out of 83 (88.0%) MDR strains harbored a mutation located in the pncA gene, including 55 (75.3%, 55/73) of single nucleotide substitutions and 18 (24.7%, 18/73) of frameshift mutation, while no genetic mutation associated with PZA resistance was found in the rpsA gene. The pncA expression of strains harboring substitution from A to G at position −11 in the promoter region of pncA was significantly lower than that of H37Rv (P < 0.01). Conclusions In conclusion, our data have demonstrated that the analysis of the pncA gene rather than rpsA gene provides rapid and accurate information regarding PZA susceptibility for MDR-TB isolates in Chongqing. In addition, loss of pncA expression caused by promoter mutation confers PZA resistance in MDR-TB isolates. |
url |
http://link.springer.com/article/10.1186/s12879-017-2761-6 |
work_keys_str_mv |
AT yupang prevalenceandmolecularcharacterizationofpyrazinamideresistanceamongmultidrugresistantmycobacteriumtuberculosisisolatesfromsouthernchina AT damianzhu prevalenceandmolecularcharacterizationofpyrazinamideresistanceamongmultidrugresistantmycobacteriumtuberculosisisolatesfromsouthernchina AT huiwenzheng prevalenceandmolecularcharacterizationofpyrazinamideresistanceamongmultidrugresistantmycobacteriumtuberculosisisolatesfromsouthernchina AT jingshen prevalenceandmolecularcharacterizationofpyrazinamideresistanceamongmultidrugresistantmycobacteriumtuberculosisisolatesfromsouthernchina AT yanhu prevalenceandmolecularcharacterizationofpyrazinamideresistanceamongmultidrugresistantmycobacteriumtuberculosisisolatesfromsouthernchina AT jieliu prevalenceandmolecularcharacterizationofpyrazinamideresistanceamongmultidrugresistantmycobacteriumtuberculosisisolatesfromsouthernchina AT yanlinzhao prevalenceandmolecularcharacterizationofpyrazinamideresistanceamongmultidrugresistantmycobacteriumtuberculosisisolatesfromsouthernchina |
_version_ |
1724798762039115776 |